降逆理气汤在治疗消化系统恶性肿瘤术后胃瘫综合征的临床研究
|
摘要
目的研究降逆理气汤在治疗消化系统恶性肿瘤术后胃瘫综合征的疗效。方法方便选取2014年1月—2015年12月住院的110例消化系统恶性肿瘤术后胃瘫综合征的患者作为该次研究对象,随机分为治疗组60例和对照组50例,治疗组用在常规西医治疗的基础上加用降逆理气汤中药方剂治疗。对照组常规西医治疗加莫沙必利5 mg口服和胃复安10 mg静脉点滴。比较两组治疗前、治疗后3、7 d血清中胃动素、IL-6水平;治疗后饮食恢复正常的时间。结果治疗组治疗前胃动素水平(256.2±15.2)mg/m L与对照组(262.9±11.5)mg/m L比较差异无统计学意义(P>0.05);治疗组治疗后第3天(352.1±19.2)mg/m L、第7天胃动素水平(485.4±18.1)mg/m L明显高于对照组(293.2±14.1)、(371.6±13.2),差异有统计学意义(P<0.05);治疗组治疗前IL-6水平(23.2±3.2)pg/m L与对照组(24.3±5.2)pg/m L比较差异无统计学意义(P>0.05);治疗组治疗后第3天(19.4±2.1)pg/m L、第7天IL-6水平(13.2±4.2)pg/m L显著低于对照组(22.4±6.2)pg/m L、(19.4±7.1)pg/m L,差异有统计学意义(P<0.05);两组治疗后饮食恢复正常的时间比较:治疗组饮食恢复正常时间(11.2±1.3)d明显短于对照组(18.5±2.6)d,两组差异有统计学意义(P<0.05)。结论降逆理气汤对治疗消化系统恶性肿瘤术后胃瘫综合征有良好的疗效,能够促进胃瘫综合征患者快速康。
Objective To research the curative effect of gastroparesis syndrome after Jiangni Liqi decoction in treatment of digestive system malignant tumors. Methods 100 cases of patients with gastroparesis syndrome after the digestive system malignant tumors treated in our hospital from January 2014 to December 2015 were selected and randomly divided into two groups, the treatment group with 60 groups adopted the Jiangni Liqi decoction on the basis of the routine western medicine,while the control group adopted the routine western medicine and oral administration of 5mg mosapride and intravenous injection of 10 mg metoclopramide, and the metoclopramide in serum and IL-6 levels before treatment and at 3、7 d after treatment and the time of dieting returning to normal were compared between the two groups. Results The difference in the metoclopramide level before treatment between the treatment group and the control group was not statistically significant,[(256.2±15.2)mg/m L vs(262.9±11.5)mg/m L](P>0.05), and the metoclopramide levels at 3、7 d after treatment in the treatment group were obviously higher than those in the control group [(352.1±19.2),(485.4±18.1)mg/m L vs(293.2±14.1),(371.6±13.2)mg/m L], and the differences were statistically significant(P<0.05), and the difference in the IL-6 level before treatment between the treatment group and the control group was not statistically significant[(23.2±3.2)pg/m L vs(24.3±5.2)pg/m L](P>0.05), and the IL-6 levels at 3、7 d after treatment were obviously lower than those in the control group [(19.4±2.1),(13.2±4.2)pg/m L vs(22.4±6.2),(19.4±7.1)pg/m L], and the differences were statistically significant(P<0.05), after treatment, the time to return to normal of dieting was obviously shorter than that in the control group [(11.2±1.3)d vs(18.5±2.6)d], and the difference between groups was statistically significant(P<0.05). Conclusion The curative effect of Jiangni Liqi decoction in treatment of digestive system malignant tumors is good, which can promote the rapid recovery of gastroparesis syndrome.
Objective To research the curative effect of gastroparesis syndrome after Jiangni Liqi decoction in treatment of digestive system malignant tumors. Methods 100 cases of patients with gastroparesis syndrome after the digestive system malignant tumors treated in our hospital from January 2014 to December 2015 were selected and randomly divided into two groups, the treatment group with 60 groups adopted the Jiangni Liqi decoction on the basis of the routine western medicine,while the control group adopted the routine western medicine and oral administration of 5mg mosapride and intravenous injection of 10 mg metoclopramide, and the metoclopramide in serum and IL-6 levels before treatment and at 3、7 d after treatment and the time of dieting returning to normal were compared between the two groups. Results The difference in the metoclopramide level before treatment between the treatment group and the control group was not statistically significant,[(256.2±15.2)mg/m L vs(262.9±11.5)mg/m L](P>0.05), and the metoclopramide levels at 3、7 d after treatment in the treatment group were obviously higher than those in the control group [(352.1±19.2),(485.4±18.1)mg/m L vs(293.2±14.1),(371.6±13.2)mg/m L], and the differences were statistically significant(P<0.05), and the difference in the IL-6 level before treatment between the treatment group and the control group was not statistically significant[(23.2±3.2)pg/m L vs(24.3±5.2)pg/m L](P>0.05), and the IL-6 levels at 3、7 d after treatment were obviously lower than those in the control group [(19.4±2.1),(13.2±4.2)pg/m L vs(22.4±6.2),(19.4±7.1)pg/m L], and the differences were statistically significant(P<0.05), after treatment, the time to return to normal of dieting was obviously shorter than that in the control group [(11.2±1.3)d vs(18.5±2.6)d], and the difference between groups was statistically significant(P<0.05). Conclusion The curative effect of Jiangni Liqi decoction in treatment of digestive system malignant tumors is good, which can promote the rapid recovery of gastroparesis syndrome.
引文
[1]黄烈弥,喻佳丽,杨秋萍,等.干扰电联合特定电磁波治疗腹部手术后胃瘫综合征[J].中华物理医学与康复杂志,2014,36(7):562-563.
[2]隋洪帅,谢永新,王明翠,等.肾病综合征与术后胃瘫综合征患者ALB及胆红素的对比分析[J].军事医学,2015,39(12):944-947,951.
[3]李艳,范晓萍,郭雄波,等.穴位注射治疗胃手术后胃瘫综合征疗效观察[J].中国全科医学,2014,17(1):113-114.
[4]张鸣杰,张国雷,袁文斌,等.胃癌术后胃瘫综合征的危险因素分析及其对预后的影响[J].中华胃肠外科杂志,2013,16(2):163-165.
[5]兰兰,邵燕飞,郑小春,等.1例手术后胃瘫综合征营养支持方案调整及药学监护[J].医药导报,2016,35(9):1010-1012.
[6]王东,谭广,巩鹏,等.胃大部切除术后胃瘫综合征的治疗[J].中国普通外科杂志,2006,15(2):157-159.
[7]刘玉芬,王文跃,周雷,等.综合性心理干预应用于腹部手术后胃瘫综合征患者的效果评价[J].中国实用护理杂志,2012,28(16):13-16.
[8]谢玲玲.理气降逆汤治疗反流性食管炎52例[J].浙江中医杂志,2012,47(12):883.
[2]隋洪帅,谢永新,王明翠,等.肾病综合征与术后胃瘫综合征患者ALB及胆红素的对比分析[J].军事医学,2015,39(12):944-947,951.
[3]李艳,范晓萍,郭雄波,等.穴位注射治疗胃手术后胃瘫综合征疗效观察[J].中国全科医学,2014,17(1):113-114.
[4]张鸣杰,张国雷,袁文斌,等.胃癌术后胃瘫综合征的危险因素分析及其对预后的影响[J].中华胃肠外科杂志,2013,16(2):163-165.
[5]兰兰,邵燕飞,郑小春,等.1例手术后胃瘫综合征营养支持方案调整及药学监护[J].医药导报,2016,35(9):1010-1012.
[6]王东,谭广,巩鹏,等.胃大部切除术后胃瘫综合征的治疗[J].中国普通外科杂志,2006,15(2):157-159.
[7]刘玉芬,王文跃,周雷,等.综合性心理干预应用于腹部手术后胃瘫综合征患者的效果评价[J].中国实用护理杂志,2012,28(16):13-16.
[8]谢玲玲.理气降逆汤治疗反流性食管炎52例[J].浙江中医杂志,2012,47(12):883.